Living in sunny dry Melbourne, (well not today!), I decided to head into the city for the PNV AUG.
David Williams* was colourful and forthright as usual, and good updates from David, Ed*, Swami*, and our Aussie sales manager (Valerie?)*.
Broadening markets in geography and product segment lies ahead of us, so the company is the growing in all respects, benefitting from greater sales staff and R&D head count.
Not only do we have a pretty successful share metrics, but the platform for future benefit is in place where future growth should just happen. Just as important, well almost, we holders are supporting a company which does good for the patients via a successful product, but the culture and quality of the individuals and the company is very special. This makes me a very relaxed shareholder, and very happy with being overweight as far as portfolio weighting.
* I spoke to all of these people. Shareholder, in my humble opinion we are in good hands here. not financial advice, my opinon.
Ann: Results of 2022 Annual General Meeting, page-2
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.04 |
Change
-0.030(1.45%) |
Mkt cap ! $1.409B | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.11 | $2.03 | $1.727M | 838.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 299194 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.04 | 1559 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |